Company intelligence / Profile preview
Gyre Pharmaceuticals
Beijing, Beijing, Chinagyretx.com ↗
- Ownership
- Public · GYRE
- Employees
- ~579
- Development stage
- Commercial
01
Overview
Gyre Pharmaceuticals is a commercial-stage biopharmaceutical company specializing in innovative therapies for organ fibrosis. Its flagship product ETUARY® (pirfenidone) is approved for idiopathic pulmonary fibrosis and has maintained significant market share since its launch. The company’s lead pipeline asset Hydronidone/F351 has demonstrated statistically significant regression of CHB-associated liver fibrosis in pivotal Phase III trials and received Breakthrough Therapy designation from Chinese regulators. Additional assets target fibrotic diseases across multiple organs with several candidates advancing through clinical development.
- Therapeutic areas
- Metabolic DisordersPulmonologyImmunologyHematologyRheumatologyGastroenterologyCardiovascularNephrologyInfectious Diseases
- Modalities
- Small moleculesCaspase inhibitorsEndothelin receptor agonists
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Gyre Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gyre Pharmaceuticals.